Biological and Medicinal Chemistry

Lysosome Targeting Chimeras (LYTACs) for the Degradation of Secreted and Membrane Proteins

Abstract

Targeted protein degradation is a powerful strategy to address the canonically undruggable proteome. However, current technologies are limited to targets with cytosolically-accessible and ligandable domains. Here, we designed and synthesized conjugates capable of binding both a cell surface lysosome targeting receptor and the extracellular domain of a target protein. These lysosome targeting chimeras (LYTACs) consist of an antibody fused to agonist glycopeptide ligands for the cation-independent mannose-6-phosphate receptor (CI-M6PR). LYTACs enabled a CRISPRi knockdown screen revealing the biochemical pathway for CI-M6PR-mediated cargo internalization. We demonstrated that LYTACs mediate efficient degradation of Apolipoprotein-E4, epidermal growth factor receptor (EGFR), CD71, and programmed death-ligand 1 (PD-L1). LYTACs represent a modular strategy for directing secreted and membrane proteins for degradation in the context of both basic research and therapy.

Content

Thumbnail image of 191111 CombinedV2.pdf

Supplementary material

Thumbnail image of Supplemental Data 1.xlsx
Supplemental Data 1
Thumbnail image of Supplemental Data 2.xlsx
Supplemental Data 2